Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Azurrx Biopharma Inc (AZRX)

3.13 -0.01 (-0.32%)

12-11 09:30

Open:

3.08

Pre. Close:

3.14

High:

3.13

Low:

3.13

Volume:

3

Market Cap:

36M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.16 - 3.16

3.16 - 3.16

Low:

2.79 - 2.79

2.79 - 2.79

Close:

3.05 - 3.08

3.08 - 3.16

Technical analysis  (as of: 2017-12-08 4:54:41 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 3.98     One year: 4.65

Support:

Support1: 2.79    Support2: 2.40

Resistance:

Resistance1: 3.41    Resistance2: 3.98

Pivot:

3.09

Moving Averages:

MA(5): 3.16     MA(20): 3.02

MA(100): 3.69     MA(250): 3.85

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.04

%K %D:

%K(14,3): 61.07     %D(3): 70.64

RSI:

RSI(14): 50.44

52-Week:

High: 5.25  Low: 2.4  Change(%): -30.2

Average Vol(K):

3-Month: 6473  10-Days 2702

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AZRX has closed below upper band by 41.4%. Bollinger Bands are 41.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to AZRX's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 27 Sep 2017 12:22:30 GMT
AzurRx BioPharma and Mayoly-Spindler Announce Positive MS1819-SD Phase II Data ...

Sat, 12 Aug 2017 00:56:15 GMT
BRIEF-Azurrx Biopharma enters into sublicense agreement with Transchem

Fri, 20 Oct 2017 12:22:30 GMT
AzurRx BioPharma and Mayoly Spindler Announce MS1819-SD Investigational ...

Mon, 04 Dec 2017 12:04:24 GMT
AzurRx BioPharma to Present at the Biotech Showcase 2018 Conference (January 8th)

Mon, 12 Dec 2016 12:56:15 GMT
WallachBeth Capital Initiates Research Coverage of AzurRx BioPharma

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  NA

Industry:  NA

Shares Out. (M)

11.55

Shares Float (M)

5.68

% Held by Insiders

40.65

% Held by Institutions

8.09

Shares Short (K)

30

Shares Short Prior Month (K)

27

Stock Financials

EPS

-1.640

EPS Est. Current Year

-0.850

EPS Est. Next Year

-0.670

EPS Est. Next Quarter

-0.160

Forward EPS

-0.790

Book Value (p.s.)

0.420

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-68.3

Return on Equity (ttm)

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.661

Qtrly Earnings Growth

Operating Cash Flow (M)

-6.67

Levered Free Cash Flow (M)

-9.36

atoplab.com

Valuation

P/E

-1.91

P/E Growth Ratio

0.04

P/BV

7.48

P/S

P/CF

-5.44

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.